Literature DB >> 33413026

Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity.

Liam Townsend1,2, Joanne Dowds3, Kate O'Brien3, Grainne Sheill3,3, Adam H Dyer4, Brendan O'Kelly1, John P Hynes5, Aoife Mooney6, Jean Dunne6, Cliona Ni Cheallaigh1,2, Cliona O'Farrelly7,8, Nollaig M Bourke4, Niall Conlon6,9, Ignacio Martin-Loeches10,2, Colm Bergin1,2, Parthiban Nadarajan11, Ciaran Bannan1,2.   

Abstract

Rationale: Much is known about the acute infective process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of the coronavirus disease (COVID-19) pandemic. The marked inflammatory response and coagulopathic state in acute SARS-CoV-2 infection may promote pulmonary fibrosis. However, little is known about the incidence and seriousness of post-COVID-19 pulmonary pathology.
Objectives: To describe the respiratory recovery and self-reported health after infection at the time of outpatient attendance.
Methods: Infection severity was graded into three groups: 1) not requiring admission, 2) requiring hospital admission, and 3) requiring intensive care unit care. Participants underwent chest radiography and a 6-minute walk test (6MWT). Fatigue and subjective return to health were assessed, and concentrations of CRP (C-reactive protein), IL-6 (interleukin-6), sCD25 (soluble CD25), and D-dimer were measured. The associations between initial illness and abnormal chest X-ray findings, 6MWT distance, and perception of maximal exertion were investigated.
Results: A total of 487 patients were offered an outpatient appointment, of whom 153 (31%) attended for assessment at a median of 75 days after diagnosis. A total of 74 (48%) had required hospital admission during acute infection. Persistently abnormal chest X-ray findings were seen in 4%. The median 6MWT distance covered was 460 m. A reduced distance covered was associated with frailty and length of inpatient stay. A total of 95 (62%) patients believed that they had not returned to full health, whereas 47% met the case definition for fatigue. Ongoing ill health and fatigue were associated with an increased perception of exertion. None of the measures of persistent respiratory disease were associated with initial disease severity. Conclusions: This study highlights the rates of objective respiratory disease and subjective respiratory symptoms after COVID-19 and the complex multifactorial nature of post-COVID-19 ill health.

Entities:  

Keywords:  COVID-19; breathlessness; respiratory complications

Year:  2021        PMID: 33413026     DOI: 10.1513/AnnalsATS.202009-1175OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  60 in total

1.  Characteristics of COVID-19 Inpatients in Rehabilitation Units during the First Pandemic Wave: A Cohort Study from a Large Hospital in Champagne Region.

Authors:  Amandine Rapin; Peter-Joe Noujaim; Redha Taiar; Sandy Carazo-Mendez; Gaetan Deslee; Damien Jolly; François Constant Boyer
Journal:  Biology (Basel)       Date:  2022-06-20

2.  Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

Authors:  Brendan O'Kelly; Louise Vidal; Tina McHugh; James Woo; Gordana Avramovic; John S Lambert
Journal:  Brain Behav Immun Health       Date:  2022-07-03

3.  Post COVID-19 fitness to dive assessment findings in occupational and recreational divers.

Authors:  Bengusu Mirasoglu; Gulsen Yetis; Mustafa Erelel; Akin Savas Toklu
Journal:  Diving Hyperb Med       Date:  2022-03-31       Impact factor: 1.228

4.  Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID.

Authors:  Manuela Funke-Chambour; Pierre-Olivier Bridevaux; Christian F Clarenbach; Paola M Soccal; Laurent P Nicod; Christophe von Garnier
Journal:  Respiration       Date:  2021-06-04       Impact factor: 3.580

5.  Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health.

Authors:  Liam Townsend; Adam H Dyer; Aifric Naughton; Rachel Kiersey; Dean Holden; Mary Gardiner; Joanne Dowds; Kate O'Brien; Ciaran Bannan; Parthiban Nadarajan; Jean Dunne; Ignacio Martin-Loeches; Padraic G Fallon; Colm Bergin; Cliona O'Farrelly; Cliona Ni Cheallaigh; Nollaig M Bourke; Niall Conlon
Journal:  Front Immunol       Date:  2021-05-07       Impact factor: 7.561

Review 6.  Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.

Authors:  Timothy L Wong; Danielle J Weitzer
Journal:  Medicina (Kaunas)       Date:  2021-04-26       Impact factor: 2.430

7.  Long Haulers-What Is the Evidence for Post-COVID Fatigue?

Authors:  Andreas Stengel; Nisar Malek; Stephan Zipfel; Siri Goepel
Journal:  Front Psychiatry       Date:  2021-05-21       Impact factor: 4.157

Review 8.  The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.

Authors:  Narges Moghimi; Mario Di Napoli; José Biller; James E Siegler; Rahul Shekhar; Louise D McCullough; Michelle S Harkins; Emily Hong; Danielle A Alaouieh; Gelsomina Mansueto; Afshin A Divani
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-28       Impact factor: 5.081

Review 9.  Measures of physical performance in COVID-19 patients: a mapping review.

Authors:  Carla Simonelli; Mara Paneroni; Michele Vitacca; Nicolino Ambrosino
Journal:  Pulmonology       Date:  2021-06-24

10.  Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection.

Authors:  Liam Townsend; Adam H Dyer; Patrick McCluskey; Kate O'Brien; Joanne Dowds; Eamon Laird; Ciaran Bannan; Nollaig M Bourke; Cliona Ní Cheallaigh; Declan G Byrne; Rose Anne Kenny
Journal:  Nutrients       Date:  2021-07-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.